+44 (0) 1865 606333 enquiries@visibleanalytics.co.uk

HTAi 2021 Virtual
19-23 June

We are looking forward to sharing Visible Analytics and our colleagues’ latest research.

Check out our work and do not hesitate to get in touch.


PN07: Bridging Evidence Gaps in HTA: Building Confidence In Analytical Methods for Combining Results from Randomized and Non-Randomized Studies

with Prof. Keith Abrams, MSc, PhD, Cstat and Dr. Grammati Sarri, DiDS, MSc, PhD, and co-panellists Dalia Dawoud, MSc, PhD, Prof. Sofia Dias, PhD, and Thomas Debray, MSc, PhD.

Can analytical methods for combining randomized with non-randomized evidence address issues around uncertainty and build trust when estimating treatment effects for new technologies? The panel will debate this and explore the potential of using these novel analytical methods in HTA. It will also propose a newly developed framework for their integration in decision-making and explore acceptance of its use.

Tuesday, 22 June 2021

05:00 – 06:15 (UTC) Panel session 2

Oral Presentations

Use of Real-World Evidence in Survival Analysis Adjusting for Treatment Crossover in Cutaneous T-Cell Lymphoma

presented by Rachel Evans, MSc

Real-World Evidence is useful for validating crossover adjustment approaches, particularly when the adjustment is required because a trial does not accurately reflect an HTA-relevant population. We use the MAVORIC trial advanced stage mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma population and data from the Hospital Episodes Statistics to explore and validate crossover adjustment methods.

Will be available on virtual meeting platform by Thursday, 17 June 2021.